¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"activated graft"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • heteroplastic graft
    ÀÌÁ¾À̽Ä
  • heterotopic graft
    ´Ù¸¥ÀÚ¸®À̽Ä
  • homoplastic graft
    µ¿Á¾À̽Ä
  • isoplastic graft
    µ¿ÀÎÀÚ°£À̽Ä
  • inlay bone graft
    ¼Ó³Ö±â»ÀÀ̽Ä, ºÀ¹ÚÀÌ»ÀÀ̽Ä, Àη¹À̰ñÀ̽Ä
  • inlay graft
    ¼Ó³Ö±âÀ̽Ä, Àη¹ÀÌÀ̽Ä
  • interfascicular graft
    ´Ù¹ß»çÀÌÀ̽Ä
  • intramedullary bone graft
    ¼ÓÁú³»»ÀÀ̽Ä, °ñ¼ö³»°ñÀ̽Ä
  • lamellar graft
    ÃþÆÇÀ̽Ä, Ç¥ÃþÀÌ½ÄÆí
  • mucosal graft
    Á¡¸·À̽Ä
  • mucosal graft inlay technique
    ¼Ó³Ö±âÁ¡¸·À̽ļú
  • membranous bone graft
    ¸·»ÀÀ̽Ä, ¸·¼º°ñÀ̽Ä
  • mesh graft
    ±×¹°ÇǺÎÀ̽Ä
  • microlymphatic graft
    ¹Ì¼¼¸²ÇÁÀýÀ̽Ä
  • nerve graft
    ½Å°æÀ̽Ä
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • homoplastic graft
    (¢¡allograft) µ¿Á¾À̽Ä
  • inlay graft
    ¼Ó³Ö±âÀ̽Ä, Àη¹ÀÌÀ̽Ä
  • inlay bone graft
    ¼Ó³Ö±â»ÀÀ̽Ä, ³»Àç°ñÀ̽Ä, ºÀ¹ÚÀÌ»ÀÀ̽Ä
  • interfascicular graft
    ´Ù¹ß»çÀÌÀ̽Ä
  • intramedullary bone graft
    ¼ÓÁú³»»ÀÀ̽Ä, °ñ¼ö³»°ñÀ̽Ä
  • isoplastic graft
    µ¿ÀÎÀÚ°£À̽Ä
  • lamellar graft
    ÃþÆÇÀ̽Ä, Ç¥ÃþÀÌ½ÄÆí
  • mebranous bone graft
    ¸·¼º»ÀÀ̽Ä, ¸·¼º°ñÀ̽Ä
  • mesh graft
    ±×¹°ÇǺÎÀ̽Ä
  • microlymphatic graft
    ¹Ì¼¼¸²ÇÁÀýÀ̽Ä
  • mucosal graft
    Á¡¸·À̽Ä
  • nasal cartilage graft
    ÄÚ¿¬°ñÀ̽Ä
  • nerve graft
    ½Å°æÀ̽Ä
  • nonvascularized bone graft
    ºñÇ÷°ü»ÀÀ̽Ä
  • omental graft
    ±×¹°¸·À̽Ä
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • graft versus host reaction
    ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ(ì¹ãÕø¸ÓßâÖñ«Úãëë).
  • graft versus host reaction (GVHR)
    ´ë¼÷ÁÖÀÌ½ÄÆí¹ÝÀÀ
  • graft, free jejunal
    À¯¸®°øÀå À̽ļú
  • graft, heterotopic
    À̼ÒÀ̽Ä, ´Ù¸¥ÀÚ¸®À̽Ä
  • graft, nerve
    ½Å°æÀ̽Ĺý
  • graft, orthotopic
    µ¿¼ÒÀ̽Ä, °°ÀºÀÚ¸®À̽Ä
  • graft, perichondral cutaneous
    ¿¬°ñ¸·ÇǺÎÀ̽Ä
  • graft, second
    ÀÌÂ÷À̽Ä
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë ¼÷ÁÖº´
  • heterodermic graft
    ÀÌÁ¾½ÄÇÇ(ì¶ðúãÕù«)
  • heteroplastic graft
    ÀÌÁ¾½ÄÇÇ(¡­ãÕù«)
  • heteroplastic graft
    ÀÌÁ¾½ÄÇÇ(¡­½ÄÇÇ).
  • heteroplastic graft
    ÀÌÁ¾½ÄÇÇ(¡­ãÕù«).
  • homoplastic graft =isoplastic g.
    µ¿Á¾ÀÌ½ÄÆí(¡­ÀÌ½ÄÆí).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • epidermic graft
    Ç¥ÇÇÀ̽Ä(¡­ì¹ãÕ).
  • fascia graft
    ±Ù¸· À̽Ä(ÐÉØ¯ì¹ãÕ).
  • fat graft
    Áö¹æÀÌ½ÄÆí(¡­ÀÌ½ÄÆí).
  • fat graft
    Áö¹æÀ̽Ä
  • fat graft
    Áö¹æÀÌ½ÄÆí(¡­ì¹ãÕø¸).
  • free graft
    À¯¸®À̽Ä(ë´ìÆì¹ãÕ).
  • free graft
    À¯¸®À̽Ä(À¯ÀÌÀ̽Ä).
  • free jejunal graft
    À¯¸®°øÀå À̽ļú
  • full thickness graft
    ÀüÃþÇǺÎÀÌ½ÄÆí(¡­ù«Ý±ì¹ãÕø¸), ÀüÃþ½ÄÇÇ(¡­ãÕù«).
  • full thickness graft
    ÀüÃþÇǺÎÀÌ½ÄÆí(¡­ÇǺÎÀÌ½ÄÆí), ÀüÃþ½ÄÇÇ(¡­½ÄÇÇ).
  • gauntlet graft
    Àå°©»ó À̽İñ Æí(íæË¡ßÒì¹ãÖÍéø¸), ±äÀå°©Çü À̽Ä.
  • graft
    À̽Ä(Æí)
  • graft
    Á¶Á÷À̽Ä(ðÚòÄì¹ãÕ)
  • graft
    ÀÌ½ÄÆí
  • graft =transplantation
    Á¶Á÷À̽Ä(ðÚòÄì¹ ãÕ), ÀÌ½ÄÆí(ì¹ãÕø¸).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
C2a activated second component of complement
C3a activated third component of complement
C4a activated fourth component of complement
C6a activated sixth component of complement
C7a activated seventh component of complement
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
GVL Graft vs leukemia
GIC Graft-infiltrating cells
GIL Graft-infiltrating lymphocytes
GVH Graft-versus-host disease
GvH Graft-vs-Host
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sieve graft
    »ç»ó À̽Ä
    ¿øÇüÀÇ ¾ÆÁÖ ÀÛÀº ¸î °³ÀÇ µµ°¡ Á¦°ÅµÈ ÇǺΠÀÌ½ÄÆí. ÀÌ´Â Å« ³ëÃâµÈ ºÎÀ§¸¦ µ¤´Âµ¥ »ç¿ëµÈ´Ù.
  • skin graft thickness
    ÀüÃþ ÇǺΠÀÌ½ÄÆí
  • split skin graft
    ºÎºÐÃþ ½ÄÇǼú
  • split thickness skin graft
    ºÎºÐ Ãþ ÇǺΠÀ̽Ä
  • Thierschs skin graft
    Ƽ¸£½´ ÇǺΠÀ̽ļú
  • xenogenic graft
    ÀÌÁ¾À̽Ä
    ÀÌÁ¾ÀÇ µ¿¹°°£¿¡ À̽ÄÇÏ´Â °Í.
  • xenogenous graft
    ÀÌÁ¾ ÀÌ½ÄÆí
    ÀÌÁ¾ÀÇ µ¿¹°°£¿¡ À̽ĵǴ ½ÃÆí.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
Blair-Brown graft A split-thickness graft of intermediate thickness.
(05 Mar 2000)
bone graft Bone transplanted from a donor site to a recipient site.
See: osteoplasty.
(05 Mar 2000)
brephoplastic graft A graft from an embryo or newborn to an adult.
(05 Mar 2000)
bypass graft <surgery> An alternative blood vessel that is created by a surgeon to reroute blood flow. Grafts may be synthetic (dacryon) or autologous (a vein from the patients own leg used as a substitute for the diseased vessel).
(20 Mar 1998)
cable graft A multiple strand nerve graft arranged as a pathway for regeneration of axons.
(05 Mar 2000)
vascularised graft The state of a graft after the recipient vasculature has been connected with the vessels in the graft.
(05 Mar 2000)
partial-thickness graft A graft of portions of the skin, i.e., the epidermis and part of the dermis, or of part of the mucosa and submucosa, but not including the periosteum.
Synonym: partial-thickness graft, split-skin graft.
(05 Mar 2000)
pedicle graft A skin flap sustained by a blood-carrying stem from the donor site during transfer, in periodontal surgery, a flap used to increase the width of attached gingiva, or to cover a root surface, by moving the attached gingiva, which remains joined at one side, to an adjacent position and suturing the free end.
(05 Mar 2000)
Reverdin graft Small bits of skin, of partial or full thickness, removed from a healthy area and seeded in a site to be covered.
Synonym: Reverdin graft.
(05 Mar 2000)
graft To insert scions from one tree, or kind of tree, etc, into another; to practice grafting.
A small shoot or scion of a tree inserted in another tree, the stock of which is to support and nourish it. The two unite and become one tree, but the graft determines the kind of fruit.
A branch or portion of a tree growing from such a shoot.
<surgery> A portion of living tissue used in the operation of autoplasty.
Origin: OE. Graff, F. Greffe, originally the same word as OF. Grafe pencil, L. Graphium, Gr, fr. To write; prob. Akin to E. Carve. So named from the resemblance of a scion or shoot to a pointed pencil. Cf. Graphic, Grammar.
1. To insert (a graft) in a branch or stem of another tree; to propagate by insertion in another stock; also, to insert a graft upon. [Formerly written graff.
2.
<surgery> To implant a portion of (living flesh or akin) in a lesion so as to form an organic union.
3.
To join (one thing) to another as if by grafting, so as to bring about a close union. "And graft my love immortal on thy fame !" (Pope)
4.
To cover, as a ring bolt, block strap, splicing, etc, with a weaving of small cord or rope-yarns.
Origin: F. Greffer. See Graft.
Source: Websters Dictionary
(01 Mar 1998)
graft enhancement, immunologic The induction of prolonged survival and growth of allografts of either tumours or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunised donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity.
(12 Dec 1998)
graft occlusion <physiology> Obstruction of flow in biological or prosthetic vascular grafts.
(12 Dec 1998)
graft rejection <haematology, immunology> When donated bone marrow infused during a bone marrow transplant is rejected by the patients body or does not take.
(16 Dec 1997)
graft survival <haematology> The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host.
(12 Dec 1998)
graft-versus-host disease <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue.
When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage.
The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign.
The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs.
Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.
Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel.
Synonym: GVH disease.
Acronym: GVHD
(20 Sep 2002)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á